MetaCap

Celularity Earnings

NASDAQ: CELUHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.463-0.0049 (-1.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Celularity earnings summary

In its most recent report on Nov 20, 2026 (Sep/2026), CELU posted EPS of $-0.88. Across the last 13 reports, CELU shares moved an average of 16.3% (in either direction) in the first trading session after results, rising 5 times and falling 8 times.

Summary generated from market data by MetaCap's automated system. Methodology

CELU earnings history

Celularity reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 20, 2026—$-0.88——
Nov 13, 2026—$-0.88—-26.5%
Oct 20, 2026—$-0.12—-18.2%
Nov 14, 2025—$-0.88—+12.9%
Aug 29, 2025—$-1.02—-38.8%
May 9, 2025—$-0.84—+22.2%
Dec 6, 2024—$-0.73—-5.9%
Jan 3, 2024—$0.80—-11.4%
Aug 14, 2023—$-2.72—-6.3%
May 22, 2023—$-4.12—+17.1%
Mar 31, 2023—$1.08—+10.8%
Nov 10, 2022—$0.03—-13.8%
Aug 9, 2022—$0.32—-8.1%
May 16, 2022—$-0.48—+19.4%
Nov 12, 2021—$0.40——
Aug 19, 2021—$-2.69——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related